Drug Class
JAK1/JAK2 inhibitor
Type
brand
Active Ingredient
ruxolitinib
📋Overview
Jakafi is a medication that works by inhibiting certain enzymes known as Janus kinases (JAKs) involved in the signaling pathways of blood cell production and immune function. It is commonly associated with conditions such as myelofibrosis and polycythemia vera, which are disorders affecting the bone marrow and blood cells. Jakafi helps to address abnormal cell growth and inflammation seen in these diseases. Its use is linked to the management of symptoms and complications related to these hematologic conditions.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Jakafi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.